World of DTC Marketing

DECEMBER 11, 2020

(Mckinsey) Much of the prevailing market research on COVID-19 vaccination frames sentiment as “likely,” “unlikely,” or “neutral.” Their research has found that consumers’ attitudes towards receiving a COVID-19 vaccine fall into three primary segments.

Vaccination 227

Vaccination Vaccine Clinical Trials Clinical Trials 227

World of DTC Marketing

NOVEMBER 10, 2020

You need to ask yourself why in the hell Pfizer’s CEO would say that their vaccine is 90% effective when there is a lot more testing and review of data needed. The answer lies in looking at Pfizer’s stock price which shot up on the news as well as the false optimism of the stock market. The media has not been helpful.

Vaccination 286

Vaccination Vaccine Marketing Drugs 286

Drug Discovery World

OCTOBER 24, 2023

The DDW Turning Science into Business Summit, ‘ Cancer research opportunities and advances ’ will take place online on 16 November at 7AM PST / 10AM EDT / 3PM GMT / 4PM CET. This free summit, sponsored by Taconic, will offer expert thought leadership on cancer research, precision medicine and immunotherapy.

Vaccination 52

Vaccination Vaccine Research Clinical Development 52

Pharmaceutical Technology

MAY 16, 2023

Bavarian Nordic has completed the acquisition of Emergent BioSolutions ’ travel vaccine portfolio for an upfront payment of $274m, with the potential for the total value to rise to $384m. Following the completion of the deal, Bavarian Nordic now boasts the only oral vaccine licensed by the U.S.

Vaccination 130

Vaccination Vaccine Licensing Licensing 130

Pharmaceutical Technology

FEBRUARY 14, 2023

The US Department of Health and Human Services (HHS) and the Department of Defense have modified their existing agreement with Novavax to secure additional doses of the Covid-19 vaccine, Adjuvanted (NVX-CoV2373). million additional doses of its Covid-19 vaccine. Under the modified deal, Novavax will deliver up to 1.5

Vaccination 162

Vaccination Vaccine Protein Engineer 162

Drug Discovery World

MAY 13, 2024

Reece Armstrong speaks to Melanie Adams-Cioaba , Senior Director and General Manager of pharma (cryo-EM), Thermo Fisher Scientific about advances in vaccine design. Using structural biology as central to vaccine design and development, and to drug discovery more generally, is what we mean by “rational design.”

Vaccination 59

Vaccination Vaccine Protein Antibody 59

World of DTC Marketing

AUGUST 26, 2021

The government has latitude to protect citizens from deadly conditions, especially when the science supporting vaccination is so clear” With respect to children, parents do not have carte blanche. The bottom line is that we have to take bolder steps to get everyone vaccinated because the unvaccinated represent a danger to us all.

Vaccination 222

Vaccination Vaccine Contamination Regulation 222

World of DTC Marketing

DECEMBER 3, 2020

Another TED talk on the evils of prescription drug marketing was filled with misinformation as usual. Today consumers don’t run to their doctor after seeing a DTC ad, they do their research, and in some cases, the ads actually help them identify potential health problems. What about marketing to doctors?

Marketing 181

Marketing Drugs Doctors Doctor 181

BioTech 365

JULY 28, 2021

COVID-19 Vaccine Development Tools Market Research Report 2021 – ResearchAndMarkets.com COVID-19 Vaccine Development Tools Market Research Report 2021 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “COVID-19 Vaccine Development Tools Market Size, Share & Trends Analysis Report by Technology, by Application (Vaccine (..)

Vaccination 40

Vaccination Vaccine Marketing Development 40

NPR Health - Shots

AUGUST 9, 2022

There isn't currently a Lyme disease vaccine on the U.S. Researchers are hoping to change that. Image credit: Bertrand Guay/AFP via Getty Images)

Clinical Trials 145

Clinical Trials Clinical Trials Vaccination Vaccine 145

BioTech 365

JULY 9, 2021

Africa Vaccine Market Research Report 2021: Prospects, Trends Analysis, Market Size and Forecasts up to 2026 – ResearchAndMarkets.com Africa Vaccine Market Research Report 2021: Prospects, Trends Analysis, Market Size and Forecasts up to 2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Africa Vaccine … Continue (..)

Marketing 40

Marketing Vaccination Vaccine Research 40

BioTech 365

FEBRUARY 12, 2021

United States Travel Vaccines Market Research Report 2021: Focus on Attenuated Vaccines, Conjugate Vaccines, DNA Vaccines, Inactive Vaccines, and Recombinant Vector Vaccines – ResearchAndMarkets.com United States Travel Vaccines Market Research Report 2021: Focus on Attenuated Vaccines, Conjugate Vaccines, DNA Vaccines, … Continue reading (..)

DNA 40

DNA Vaccination Vaccine Marketing 40

BioTech 365

FEBRUARY 4, 2022

Global HIV Vaccines Market Research Report to 2027 – Featuring AlphaVax, Crucell and Novartis Among Others – ResearchAndMarkets.com Global HIV Vaccines Market Research Report to 2027 – Featuring AlphaVax, Crucell and Novartis Among Others – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “HIV Vaccines … (..)

Vaccination 40

Vaccination Vaccine Marketing Research 40

Pharmaceutical Technology

AUGUST 17, 2022

Merck (MSD outside North America) has entered a partnership agreement with Orna Therapeutics for discovering, developing and marketing various programmes based on next-generation RNA technology. These programmes will include therapies and vaccines in infectious disease and oncology areas.

RNA 147

RNA Vaccination Vaccine In-Vivo 147

Pharmaceutical Technology

NOVEMBER 30, 2022

in a project agreement from the US government for developing self-amplifying RNA (saRNA) vaccine technology against advanced and emergent viral threats. Development of vaccines to Phase I trials under the five-year $59m prototype project comprises additional $28.4m in milestone payments.

Vaccination 147

Vaccination Vaccine Development Gene Therapy 147

Drug Discovery World

FEBRUARY 14, 2024

Vaccination responses need to be rapid, efficacious and cost-effective if they are to outpace new viral threats emerging across the globe, says Jian He (Jason) , Chemistry, Manufacturing and Controls (CMC) Head, WuXi Vaccines. This would give more people much faster access to more effective vaccines.

Protein 59

Protein Vaccination Vaccine Manufacturing 59

BioTech 365

AUGUST 11, 2021

Anthrax Vaccine Market Research Report 2021: Global Growth, Trends, COVID-19 Impact, and Forecasts to 2026 – ResearchAndMarkets.com Anthrax Vaccine Market Research Report 2021: Global Growth, Trends, COVID-19 Impact, and Forecasts to 2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Anthrax Vaccine Market – (..)

Vaccination 40

Vaccination Vaccine Marketing Research 40

BioTech 365

JULY 1, 2021

United States Vaccines Market Research Report 2021: Size, Top 45 Vaccines Brand In-Depth Analysis, Trends, Shares, Insights, and Forecasts to 2027 – ResearchAndMarkets.com United States Vaccines Market Research Report 2021: Size, Top 45 Vaccines Brand In-Depth Analysis, Trends, Shares, Insights, … Continue reading →

Branding 40

Branding Vaccination Vaccine Marketing 40

BioTech 365

DECEMBER 28, 2020

Global Foot And Mouth Disease Vaccines Market Research During 2020-2024 | Industrial Analysis Report | Technavio Global Foot And Mouth Disease Vaccines Market Research During 2020-2024 | Industrial Analysis Report | Technavio LONDON–(BUSINESS WIRE)–#GlobalFootandMouthDiseaseVaccinesMarket–The foot and mouth disease (..)

Vaccination 52

Vaccination Vaccine Marketing Research 52

World of DTC Marketing

MARCH 3, 2021

A pull strategy is needed with financial incentives to repair the broken market for antibiotics and make it worthwhile for the pharma industry to bring promising drugs to market. They say that most drugmakers have exited the market because there is no money to be made while there is a lot of profit in new cancer drugs.

Marketing 174

Marketing Development Pharma Companies Drugs 174

Pharmaceutical Technology

NOVEMBER 15, 2022

When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. This also has clear advantages in healthcare settings, particularly when it comes to vaccines. In general, a prefilled syringe is clearly preferred for vaccines.”. A new challenge .

Packaging 130

Packaging Packaging Vaccination Vaccine 130

pharmaphorum

DECEMBER 22, 2022

Construction will start early next year of a new manufacturing centre in the UK with the capacity to produce 250 million vaccine doses per year, the centrepiece of a 10-year alliance between the government and US biotech Moderna. The first vaccines are due to be produced at the new facility in 2025.

Vaccination 121

Vaccination Vaccine Life Science Manufacturing 121

Pharmaceutical Technology

SEPTEMBER 15, 2022

The increase in the production of biological drugs such as vaccines, gene and cell therapies, and monoclonal antibodies, is increasing the volume of injectable drug products in the global healthcare market. Discover the top commercial dose injectables companies in contract marketing.

Marketing 130

Marketing Containment Production Sales 130

Medical Xpress

JANUARY 25, 2023

A new COVID-19 vaccine based on a different platform than current vaccines on the market has been tested in humans for the first time by researchers at Radboud university medical center. Administration of this vaccine in healthy study participants was well tolerated and led to a good immune response.

Vaccination 79

Vaccination Vaccine Immune Response Marketing 79

World of DTC Marketing

AUGUST 3, 2020

QUICK READ: As COVID-19 vaccines enter Phase III trials one has to wonder just how transparent pharma companies will be with the data. Personally I would want to know as much as I can before I ask for the vaccine but I also know that greed can make people do stupid things and there is a lot of money at stake here.

Vaccination 155

Vaccination Vaccine Immune Response Pharma Companies 155

BioTech 365

SEPTEMBER 16, 2021

United States Vaccine Transport Market Report 2021: Focus on Hospitals, Epidemic Prevention Station, Pharmaceutical Manufacturers & Distributors, & Clinical Research Organizations – ResearchAndMarkets.com United States Vaccine Transport Market Report 2021: Focus on Hospitals, Epidemic Prevention Station, Pharmaceutical Manufacturers (..)

Clinical Research 40

Clinical Research Manufacturing Vaccination Vaccine 40

Drug Discovery World

OCTOBER 5, 2023

Join DDW’s Megan Thomas and Reece Armstrong with sponsors Taconic for the first DDW Turning Science into Business Summit, ‘ Cancer research opportunities and advances ’, on 16 November at 7AM PDT / 10AM EST / 3PM GMT / 4PM CET. Find out the answer to questions such as: Where is the opportunity in the cancer research market?

Research 52

Research Antibody Medicine RNA 52

Pharmaceutical Technology

NOVEMBER 23, 2022

Innovations in biotechnology are advancing the biopharmaceutical market, enabling the treatment of complex diseases with next-generation therapeutics synthesised or extracted from a biological source. Lifted by increased interest after the onset of the Covid-19 pandemic, the sector is expected to balloon to US$853 billion by 2030.

Marketing 130

Marketing Gene Therapy Life Science Manufacturing 130

Drug Discovery World

OCTOBER 4, 2023

Join DDW for its Turning Science into Business Summit: Cancer research opportunities and advances. The 2-hour Summit will outline areas of advancement and opportunity in the cancer research market and will consist of presentations from experts in the field, as well as a panel discussion.

Research 52

Research Vaccination Vaccine Marketing 52

Advarra

JANUARY 11, 2024

The applications of mRNA-based therapies in cancer research represent one of the next groundbreaking steps toward improved cancer treatments. While mRNA usage has played several roles in clinical research , oncology researchers in particular are eager to explore the possibilities of mRNA-based cancer vaccines.

Vaccination 52

Vaccination Vaccine Protein Antibody 52

Drug Discovery World

OCTOBER 26, 2023

Register for the DDW Turning Science into Business Summit, ‘Cancer research opportunities and advances’, to hear insight and expertise from leading figures. The free two-hour summit will outline areas of opportunity in the oncology market and will feature insights from thought leaders in cancer research, precision medicine and immunotherapy.

Research 52

Research Antibody Vaccination Vaccine 52

pharmaphorum

FEBRUARY 25, 2021

Pfizer/BioNTech’s mRNA vaccine against COVID is a technical marvel – but the ultra-cool temperatures required for storage and stability has been tricky to handle. The company announced a phase 1 trial is beginning of its nasal spray vaccine just as scientists in the UK said they are considering a similar approach.

Vaccination 109

Vaccination Vaccine Immune Response Trials 109

Pharmaceutical Technology

DECEMBER 21, 2022

Moderna and the UK government have entered a ten-year strategic collaboration to build a messenger ribonucleic acid (mRNA) research, development and manufacturing facility in the country. Additionally, the centre is anticipated to have to capacity to make up to 250 million doses of vaccines per year.

Gene Therapy 351

Gene Therapy Vaccination Vaccine Manufacturing 351

XTalks

OCTOBER 4, 2023

Health economics and outcomes research (HEOR) and market access strategies play a critical role in ensuring that newly approved therapies are made available to patients. Professionals in these roles are facing new challenges when it comes to negotiating coverage for many of the new, innovative treatments that are coming to market.

Marketing 105

Marketing Development Drugs Gene Therapy 105

The Pharma Data

JUNE 1, 2022

has been appointed Senior Vice President and Head of the Company’s Vaccine Research & Development (R&D) organization effective August 1, succeeding Kathrin U. Anderson most recently served as Vice President and Chief Scientific Officer for Bacterial Research and Hospital within the Vaccine R&D organization.

Vaccination 40

Vaccination Vaccine Development Research 40

XTalks

SEPTEMBER 21, 2023

announced that the first participant has been dosed in a new Phase I trial for an innovative HIV vaccine candidate, VIR-1388. Since 2004, the NIAID has been championing the discovery and development of the cytomegalovirus (CMV) vector used to deliver the HIV vaccine material to the immune system without causing disease.

Vaccination 59

Vaccination Vaccine Trials Clinical Trials 59

pharmaphorum

MARCH 1, 2022

The primary care setting offers huge potential for commercial research. This was, and still is being, demonstrated through the UK’s COVID-19 vaccine research successes. What is the role of primary care in research? Efficient models of research delivery and new ways of working. The webinar will cover.

Clinical Research 82

Clinical Research Research Vaccination Vaccine 82